Lapatinib ditosylate: expanding therapeutic options for receptor tyrosine-protein kinase erbB-2-positive breast cancer.

Authors : Awada A, Saliba W, Bozovic-Spasojevic I
Year : 2011
Journal : Drugs Today (Barc)
Volume : 47(5)
Pages : 335-45